Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Review1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Life Sci1
Search Results
Sort by
- BookErin E. Jobst, Peter C. Panus, Marieke Kruidering-Hall.Summary: "The goal of this book is to provide a comprehensive - yet focused - foundation in pharmacology to help rehabilitation professionals understand how medication use may alter the clinical presentation of our patients as well as their responses to therapeutic interventions. In this second edition, two licensed physical therapists (Drs. Jobst and Panus) with extensive training in pharmacology worked closely with Dr. Marieke Kruidering-Hall, a pharmacologist previously involved in medical pharmacology texts. The information follows the sequence of traditional pharmacology textbooks and integrated organ systems-based curricula. The initial section is a synopsis of the nature of drugs, basic principles of pharmacodynamics and pharmacokinetics, and an overview of the drug development and approval process in the United States. Subsequent chapters include drugs that affect the autonomic and central nervous systems, cardiovascular and pulmonary systems, and the endocrine, gastrointestinal, and musculoskeletal systems. A chemotherapeutic section includes chapters covering anti-microbial drugs, cancer chemotherapy agents, and drugs that modify the immune system"-- Provided by publisher.
Contents:
PART I: BASIC PRINCIPLES
Chapter 1: Introduction
Chapter 2: Pharmacodynamics
Chapter 3: Pharmacokinetics and Pharmacogenomics
PART II: DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM
Chapter 4: Introduction to Autonomic Pharmacology
Chapter 5: Drugs Affecting the Cholinergic System
Chapter 6: Sympathomimetics and Sympatholytics
Chapter 7: Antihypertensive Drugs
Chapter 8: Drugs Used in the Treatment of Angina Pectoris
Chapter 9: Drugs Used in Heart Failure
Chapter 10: Antiarrhythmic Drugs
Chapter 11: Drugs Affecting the Blood
PART III: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM
Chapter 12: Introduction to the Pharmacology of Central Nervous System Drugs
Chapter 13: Sedative-Hypnotic Drugs
Chapter 14: Antiseizure Drugs
Chapter 15: General Anesthetics
Chapter 16: Local Anesthetics
Chapter 17: Pharmacologic Management of Parkinson's Disease and Other Movement Disorders
^Chapter 18: Antipsychotic Agents and Lithium
Chapter 19: Antidepressant Agents
Chapter 20: Opioid Analgesics and Antagonists
Chapter 21: Drugs of Abuse
PART IV: SELECTED TOPICS IN ENDOCRINE FUNCTION
Chapter 22: Growth, Thyroid, and Gonadal Pharmacology
Chapter 23: Corticosteroids and Corticosteroid Antagonists
Chapter 24: Pancreatic Hormones and Antidiabetic Drugs
Chapter 25: Drugs that Affect Bone Mineral Homeostasis
Chapter 26: Antihyperlipidemic Drugs
PART V: CHEMOTHERAPEUTICS
Chapter 27: Antibacterial Agents
Chapter 28: Antiviral Agents
Chapter 29: Antifungal and Antiparasitic Agents
Chapter 30: Miscellaneous Antimicrobial Agents: Disinfectants, Antiseptics, Sterilants, and Preservatives
Chapter 31: Cancer Chemotherapy
Chapter 32: Immunopharmacology
PART VI: DRUGS AFFECTING THE MUSCULOSKELETAL SYSTEM
Chapter 33: Skeletal Muscle Relaxants
^Chapter 34: Drugs Affecting Eicosanoid Metabolism, Disease-Modifying Antirheumatic Drugs, and Drugs Used in Gout
PART VII: SPECIAL TOPICS
Chapter 35: Drugs Affecting the Respiratory System
Chapter 36: Drugs Used in Gastrointestinal Disorders.Digital AccessProviderVersionAccessPhysiotherapyAccessPhysiotherapyAccessPhysiotherapy - ArticleMundy GR.Life Sci. 1978 Oct 30;23(17-18):1735-44.